[Malondialdehyde (MDA) as a lipid peroxidation marker]

Stefan Gaweł1, Maria Wardas, Elzbieta Niedworok

  • 1Oddziału Schorzeń Układu Oddechowego Szpitala nr 2 im. dr. Karola Zahorskiego w Sosnowcu.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|March 16, 2005
PubMed

Insights

Elevated levels of malondialdehyde (MDA), a marker of lipid peroxidation, indicate increased oxidative stress. MDA measurement is valuable for assessing antioxidant status in cancer patients.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Context:

  • Free radicals initiate lipid peroxidation, a damaging cellular process.
  • Malondialdehyde (MDA) is a key end-product of polyunsaturated fatty acid peroxidation.
  • Overproduction of MDA correlates with increased free radical activity.

Purpose:

  • To highlight Malondialdehyde (MDA) as a biomarker.
  • To establish the link between MDA levels and oxidative stress.
  • To underscore the significance of MDA in cancer patient assessment.

Summary:

  • Lipid peroxidation, triggered by free radicals, results in Malondialdehyde (MDA) formation.
  • Increased free radicals lead to overproduction of MDA.
  • Malondialdehyde levels serve as indicators of oxidative stress and antioxidant status, particularly in cancer.

Impact:

  • Provides a biochemical marker for oxidative stress.
  • Facilitates the evaluation of antioxidant status in clinical settings.
  • Aids in understanding disease progression and treatment efficacy in oncology.

Related Concept Videos